Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

Fri, 01st May 2020 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

HSBC CUTS SHELL TO 'HOLD' (BUY)

----------

GOLDMAN SACHS CUTS SHELL B PRICE TARGET TO 1850 (2000) PENCE - 'BUY'

----------

BERENBERG CUTS SHELL B TO 'HOLD' (BUY) - PRICE TARGET 1440 (1450) PENCE

----------

HSBC RAISES NEXT TO 'BUY' ('HOLD') - TARGET 5570 (7050) PENCE

----------

UBS RAISES WHITBREAD TO 'BUY' ('NEUTRAL') - TARGET 3610 (4875) PENCE

----------

LIBERUM CUTS HARGREAVES LANSDOWN TO 'HOLD' ('BUY') - TARGET 1540 (2075) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE TARGET TO 1118 (1098) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 9200 (9000) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 5900 (5860) PENCE - 'HOLD'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 7900 (6900) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES RECKITT BENCKISER PRICE TARGET TO 7450 (7350) PENCE - 'BUY'

----------

HSBC RAISES RECKITT BENCKISER PRICE TARGET TO 7300 (7000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FERGUSON PRICE TARGET TO 6600 (5900) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BAE SYSTEMS PRICE TARGET TO 695 (730) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1700 (1900) PENCE - 'OUTPERFORM'

----------

UBS CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 3900 (4150) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES BARCLAYS PRICE TARGET TO 160 (150) PENCE - 'BUY'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 9500 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 165 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES SHELL PRICE TARGET TO 1150 (1140) PENCE - 'HOLD'

----------

RBC RAISES SHELL B PRICE TARGET TO 1800 (1700) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES RECKITT BENCKISER PRICE TARGET TO 6300 (5950) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS INTERNATIONAL CONSOLIDATED AIRLINES TO 'NEUTRAL' (BUY) - PRICE TARGET 250 (500) PENCE

----------

CREDIT SUISSE RAISES RECKITT BENCKISER PRICE TARGET TO 6100 (5900) PENCE - 'NEUTRAL'

----------

DZ BANK RAISES FAIR VALUE FOR RECKITT BENCKISER TO 7100 (6500) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR GLAXOSMITHKLINE TO 1950 (1900) PENCE - 'BUY'

----------

RBC RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4600) PENCE - 'UNDERPERFORM'

----------

DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 7300 (6500) PENCE - 'SELL'

----------

RBC CUTS RSA INSURANCE PRICE TARGET TO 550 (600) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 2500 (2050) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

BARCLAYS CUTS JOHN LAING PRICE TARGET TO 425 (440) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS RATHBONE BROTHERS PRICE TARGET TO 1520 (2100) PENCE - 'HOLD'

----------

LIBERUM RAISES INTEGRAFIN PRICE TARGET TO 455 (435) PENCE - 'HOLD'

----------

LIBERUM CUTS QUILTER PRICE TARGET TO 145 (185) PENCE - 'BUY'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 330 (384) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS IMI PRICE TARGET TO 800 (950) PENCE - 'UNDERPERFORM'

----------

JPMORGAN RAISES CONVATEC PRICE TARGET TO 167 (160) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 380 (400) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 330 (260) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES CONVATEC PRICE TARGET TO 180 (175) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG INITIATES AB DYNAMICS WITH 'BUY' - TARGET 2050 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.